A Study to Learn About the Effects of Two Study Medicines (Maplirpacept [PF-07901801] And Glofitamab) When Given Together In People With Relapsed Or Refractory Diffuse Large B Cell Lymphoma.

Koo Foundation Sun Yat-Sen Cancer Center, Taipei

Princess Alexandra Hospital, Brisbane

National Taiwan University Hospital, Taipei

Allina Health Cancer Institute - Abbott Northwestern Hospital, Minneapolis

Siteman Cancer Center, St Louis

Barnes-Jewish Hospital Parkview Tower, St Louis

Barnes-Jewish Hospital, St Louis

Washington University School of Medicine, St Louis

The University of Kansas Hospital, Kansas City

University of Kansas Hospital Cambridge North Tower A, Kansas City

Swedish Cancer Institute, Seattle

Swedish Medical Center, Seattle

Rambam Health Care Campus, Haifa

Sheba Medical Center, Ramat Gan

Sourasky Medical Center, Tel Aviv

Hadassah Medical Center, Jerusalem

Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya

Shizuoka Cancer Center, Nagaizumi-cho

National Hospital Organization Kyushu Cancer Center, Fukuoka